CLINICAL_TRIALS
trial_result
· 2013-01-28
Clinical Trial Update: Rizatriptan 10 MG RPD in the Treatment of Acute Migraine [Phase 4]
Summary
A Phase 4 clinical trial evaluating rizatriptan 10 mg orally disintegrating tablet for acute migraine has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Universität Duisburg-Essen | Conditions: Migraine | Phase 4 | Status: COMPLETED